Exercise in Severe Mental Illness. The PsychiActive Project 2.0

April 3, 2020 updated by: Alvaro López Moral, Universidad Pablo de Olavide

Feasibility, Adherence and Effects of Two Exercise-based Interventions in Adults With Severe Mental Illness. The PsychiActive Project 2.0

The purpose of this randomized controlled trial is to study the feasibility, adherence and effects of two exercise interventions on body weight, body composition, anthropometric and fasting blood measures, physical fitness, quality of life, and lifestyle habits in patients with severe mental illness.

Study Overview

Study Type

Interventional

Enrollment (Anticipated)

80

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Andalucia
      • Sevilla, Andalucia, Spain, 41702
        • Recruiting
        • Álvaro López Moral
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Clinical diagnosis of psychiatric disorder (ICD-10).
  • Stabilized antipsychotic medication during the last month.

Exclusion Criteria:

  • Clinical instability.
  • Substance abuse.
  • Comorbidities contraindicating.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Wearables
Adults with several mental illness
Activity trackers with adaptive weekly step goals, weekly walking groups and coaching.
Other Names:
  • Xiaomi MiBand4
Experimental: Wearables and exergames
Adults with several mental illness
Activity trackers with adaptive weekly step goals, weekly walking groups, coaching and exercise programme based on exergames (aerobic, resistance and stretching training three weekly group sessions).
Other Names:
  • Xiaomi MiBand4 and Xbox 360 Kinect

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Self-reported sedentary behavior
Time Frame: 12 weeks
In hours per week. Using the Sedentary Behaviour Questionnaire. It asks about amount of time spent doing 11 sedentary behaviours of a usual weekday and weekend day. Time in hours of each behaviour were summed separately for weekdays and weekend days, and time for an average day was calculated as (weekday hours ×5 +weekend day hours × 2)/7. Higher values represent a higher level of sedentary behavior.
12 weeks
Self-reported physical activity
Time Frame: 12 weeks
In metabolic equivalent minutes per week. Using the Simple Physical Activity Questionnaire. Higher values represent a higher level of physical activity.
12 weeks
Behavioral Regulation in Exercise
Time Frame: 12 weeks
Using the Behavioral Regulation in Exercise Questionnaire. It consists of 24 items1 with a five-point Likert scale, which varied between 1 ("Strongly Disagree") and 4 ("Strongly Agree"). The items were grouped posteriorly into six factors (with four items each). Higher values represent a higher level of motivational continuum of self-determination theory.
12 weeks
Adherence
Time Frame: 12 weeks
In percent. Adherence will be evaluated by the percentage of attendance with respect to the total number of minutes of intervention.
12 weeks
Dropout
Time Frame: 12 weeks
In percent. Dropout will be study by the percent drop relative to the total subjects began intervention.
12 weeks
Body weight
Time Frame: 12 weeks
In kilograms. Using the InBody 770 Body Composition Analyzer (Biospace Ltd, Seoul, Korea)
12 weeks
Fat mass
Time Frame: 12 weeks
In kilograms. Using the InBody 770 Body Composition Analyzer (Biospace Ltd, Seoul, Korea)
12 weeks
Lean mass
Time Frame: 12 weeks
In kilograms. Using the InBody 770 Body Composition Analyzer (Biospace Ltd, Seoul, Korea)
12 weeks
Waist circumference
Time Frame: 12 weeks
In millimeters. Using a measuring tape (Harpenden Anthropometric Tape; Holtain, Dyfed, UK) placed at the midpoint between the last rib and the iliac crest
12 weeks
Hip circumference
Time Frame: 12 weeks
In millimeters. Using a measuring tape (Harpenden Anthropometric Tape; Holtain, Dyfed, UK) placed atthe maximum width over the greater trochanters
12 weeks
Health status
Time Frame: 12 weeks
Using the Short Form 36-Item Health Survey questionnaire version 2. Examines eight domains of physical (physical functioning, physical role, body pain, and general health) and mental health status (vitality, social functioning, emotional role, and mental health). The four physical-domains are summarized into a physical component score, and the four mental-domains constitute a mental component score. Scores range from 0 to 100 points, with higher scores indicating better health status.
12 weeks
Quality of Life
Time Frame: 12 weeks
Using the European Quality of Life-5 Dimensions Questionnaire.The descriptive system contains five dimensions of health (mobility, personal care, daily activities, pain / discomfort and anxiety / depression) and each of them has three levels of severity (no problems, some moderate or severe problems and problems). Scores range from 0 to 1 point, with higher scores indicating better quality of life.
12 weeks
Self-Reported Physical Fitness
Time Frame: 12 weeks
Using "The International Fitness Scale" (IFIS) questionnaire. The IFIS consists of a Likert-type scale (range 1-5) with five response options (very poor, poor, average, good, and very good) about perceived overall fitness, and its main components are cardiorespiratory fitness, muscular strength, speed-agility, and flexibility. Higher scores indicating better physical fitness.
12 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Lower body strength
Time Frame: 12 weeks
In number of full stands. Using the 30-second chair stand test
12 weeks
Upper body strength
Time Frame: 12 weeks
In number of bicep curls. Using the 30-second arm curl test.
12 weeks
Handgrip strength
Time Frame: 12 weeks
In kilograms. Using a dynamometer (TKK 5401 Grip-D, Takey, Tokyo, Japan)
12 weeks
Cardiorespiratory fitness
Time Frame: 12 weeks
In meters. Using the 6-min walk test.
12 weeks
Lower body flexibility
Time Frame: 12 weeks
In centimeters. Using the chair sit-and-reach test
12 weeks
Upper body flexibility
Time Frame: 12 weeks
In centimeters. Using the back scratch test
12 weeks
Mood
Time Frame: 12 weeks
Using the Scale for Mood Assessment. This questionnaire valuates four moods through 16 items divided into four categories: sadness-depression, anxiety, anger/hostility and happiness. Item scores are evaluated with the Likert scales ranging from 0 to 10, higher values represent a higher level of this mood.
12 weeks
Psychopathological symptoms
Time Frame: 12 weeks
Using the Brief Symptom Inventory-18 questionnaire. Score range from 0 to 72 points. Higher values represent a higher psychopathological severity.
12 weeks
Smoking
Time Frame: 12 weeks
Using the Fagerström nicotine dependence questionnaire. Score range from 0 to 10 points. Higher values represent a higher nicotine dependece.
12 weeks
Blood glucose
Time Frame: 12 weeks
In milligram per deciliter. Collected in the morning after an overnight fast
12 weeks
Blood cholesterol
Time Frame: 12 weeks
In milligram per deciliter. Collected in the morning after an overnight fast
12 weeks
Blood triglyceride
Time Frame: 12 weeks
In milligram per deciliter. Collected in the morning after an overnight fast
12 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Diego Munguía-Izquierdo, PhD, Universidad Pablo de Olavide

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

April 20, 2020

Primary Completion (Anticipated)

May 20, 2020

Study Completion (Anticipated)

October 30, 2020

Study Registration Dates

First Submitted

March 31, 2020

First Submitted That Met QC Criteria

April 3, 2020

First Posted (Actual)

April 7, 2020

Study Record Updates

Last Update Posted (Actual)

April 7, 2020

Last Update Submitted That Met QC Criteria

April 3, 2020

Last Verified

April 1, 2020

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • CTS948AFS20

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Exercise Therapy

Clinical Trials on Exercise training for 12 weeks (wearables)

Subscribe